NCT03603119View on ClinicalTrials.gov

Midazolam Versus Dexamethasone-ondansetron in Preventing Postoperative Nausea-vomiting for Laparoscopic Surgeries

NACompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

May 1, 2018

Primary Completion Date

November 15, 2019

Study Completion Date

November 15, 2019

Conditions

Postoperative Nausea and Vomiting

Interventions

DRUG

Normal saline, Midazolam

2 cc normal saline i.v. after anaesthesia induction.2 mg of injection midazolam intravenous 30 minutes prior to the end of surgery

DRUG

Dexamethasone, ondansetron

8mg of dexamethasone i.v. after anaesthesia induction and 4 mg of ondansetron i.v. 30 minutes prior to the end of surgery.

Trial Locations (1)

110070

Institute of Liver and Biliary Sciences, New Delhi

All Listed Sponsors

lead

Institute of Liver and Biliary Sciences, India

OTHER

NCT03603119 - Midazolam Versus Dexamethasone-ondansetron in Preventing Postoperative Nausea-vomiting for Laparoscopic Surgeries | Biotech Hunter | Biotech Hunter